On 13Th January 2017, Hong Kong New Opportunities Summit Forum with 2016 “Golden Hong Kong Stock” Award Ceremony was grandly held in Shenzhen Media Group 800 Rehearsal Hall, CMS won two important awards: “The Most Valuable Pharmaceutical Company ” and “The Best Investor Relations Management”.
“Golden Hong Kong Stock” award was co-sponsored by ZhiTongCaiJing and Royal Flush Finance. The award selected listed companies with remarkable performance from each filed, after objectively evaluating data indicators, synthesizing statistics of online voting, and collecting professional judgements of institutional and media judges. Winning these two awards fully represents CMS’s brand influence in pharmaceutical industry, and the recognition and affirmation from capital market on the outstanding achievement of CMS in pharmaceutical industry, as well as active and effective investor relations management works in terms of delivering company’s development trends.
CMS focuses on searching quality drugs from the global markets, and creates value for doctors and patients by doing professional academic promotion in China market. In the future, we will continue to keep close and sincere communications with investors, and to maintain timely and transparent information disclosure, creating greater value for shareholder and partners!